Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants

Overview of attention for article published in Nature Communications, March 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 22 news outlets
twitter: 3829 X users
facebook: 3 Facebook pages

reddit: 3 Redditors
video: 1 YouTube creator

Readers on

mendeley: 31 Mendeley

Summary News X Facebook Reddit YouTube

So far, Altmetric has seen 3 Reddit threads by 3 users.

Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants

User D-R-AZ, in the COVID-19 Discussion subreddit, 26 Mar 2023

Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants

User BillyGrier, in the COVID-19 subreddit, 25 Mar 2023

Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants [TriSb92 could be useful as a nasal spray]

User m_willberg, in the Novel Coronavirus (COVID-19) subreddit, 24 Mar 2023

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.